Longest Available Clinical Outcomes After Drug-Eluting Stent Implantation for Unprotected Left Main Coronary Artery DiseaseThe DELFT (Drug Eluting stent for LeFT main) Registry
Emanuele Meliga, MD*, ,
Hector Manuel Garcia-Garcia, MD, MSc*,
Marco Valgimigli, MD, PhD ,
Alaide Chieffo, MD, PhD ,
Giuseppe Biondi-Zoccai, MD ,
Andrew O. Maree, MD||,
Stephen Cook, MD¶,
Lindsay Reardon, MD||,
Claudio Moretti, MD ,
Stefano De Servi, MD#,
Igor F. Palacios, MD, FACC||,
Stephen Windecker, MD¶,
Antonio Colombo, MD, FACC, FESC ,
Ron van Domburg, PhD*,
Imad Sheiban, MD and
Patrick W. Serruys, MD, PhD, FACC, FESC*,*
* Department of Interventional Cardiology, Erasmus Medical Centre, Erasmus University, Rotterdam, the Netherlands
Department of Interventional Cardiology, S. Giovanni Battista Hospital, University of Turin, Turin, Italy
Department of Interventional Cardiology, S. Anna Hospital, University of Ferrara, Ferrara, Italy
Department of Interventional Cardiology, S. Raffaele Hospital, Milan, Italy
|| Department of Interventional Cardiology, Massachusetts General Hospital, Boston, Massachusetts
¶ Department of Interventional Cardiology, University Hospital, Bern, Switzerland
# Department of Cardiovascular Diseases, Ospedale Civile di Legnano, Legnano (Milan) Italy.

View larger version (17K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 1 Kaplan-Meier Curves
(A) Freedom from cardiac death (CD) and myocardial infarction (MI). (B) Freedom from major adverse cardiac events (MACE). (C) Freedom from target vessel revascularization (TVR). Solid lines = elective patients (Elec); solid bold lines = whole population (Whole); dashed lines = emergent patients (Emerg). The p value represents the difference between the elective and the emergent groups.
|
|
|